Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03138083 |
| Title | OMO-1 in Solid Malignancies |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Octimet Oncology N.V. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | NLD | GBR | FRA | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mary Crowley Cancer Research | Dallas | Texas | 75251 | United States | Details | |
| University Hospital Antwerp | Edegem | Belgium | Details | |||
| Institut Bergonie | Bordeaux | France | Details | |||
| Hôpital La Timone | Marseille | France | Details | |||
| lnstitut Gustave Roussy | Villejuif | France | Details | |||
| Erasmus MC | Rotterdam | Netherlands | Details | |||
| UMCU Universitair Medisch Centrum Utrecht | Utrecht | Netherlands | Details | |||
| University College London Hospitals NHS Foundation Trust | London | United Kingdom | Details | |||
| The Christie NHS Foundation Trust | Manchester | United Kingdom | Details | |||
| The Newcastle Upon Tyne Hospitals NHS Foundation Trust | Newcastle upon Tyne | United Kingdom | Details | |||
| University of Oxford, Department of Oncology | Oxford | United Kingdom | Details |